Psychiatry and Neurology, Neurology · Santa Rosa, CA
NPI
1295765881
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3883 Airway Drive, Suite 201
Santa Rosa, CA, 95403
Phone (707) 521-7788
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
26,487 services
Medicare patients, 2024
721
Average age 73
Drug cost, 2024
$783K
4,321 prescriptions
Company payments, 2025
$15
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John R Mendius was code J0585 (injection, onabotulinumtoxina, 1 unit), 24,795 times for 37 patients. In total John R Mendius billed 26,487 services in 35 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 24,795 | 37 | $4.82 | $120K |
| 99213 Office E&M - Established | Office | 555 | 382 | $70.62 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 400 | 319 | $13.49 | $5,397 |
| 99204 Office E&M - New | Office | 138 | 138 | $126.90 | $18K |
| 99214 Office E&M - Established | Office | 121 | 111 | $85.85 | $10K |
| 64615 Musculoskeletal | Office | 88 | 27 | $126.49 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 55 | 40 | $63.48 | $3,491 |
| 99223 Hospital E&M - Initial | Facility | 54 | 53 | $133.65 | $7,217 |
| 99222 Hospital E&M - Initial | Facility | 49 | 49 | $105.15 | $5,153 |
| 99212 Office E&M - Established | Office | 22 | 21 | $43.87 | $965 |
| 95816 Neurologic | Facility | 20 | 19 | $43.01 | $860 |
| 95819 Neurologic | Facility | 20 | 19 | $44.90 | $898 |
| 99231 Hospital E&M - Subsequent | Facility | 20 | 18 | $40.40 | $808 |
| 99215 Office E&M - Established | Office | 17 | 17 | $154.88 | $2,633 |
| 95813 Neurologic | Facility | 14 | 14 | $71.23 | $997 |
By year: 2022 $228K for 18,162 services; 2023 $284K for 25,803 services; 2024 $241K for 26,487 services.
Medicare prescription drug claims, 2024
In 2024, the drug John R Mendius prescribed most often to Medicare patients was Donepezil Hcl, with 448 prescriptions and refills. In total John R Mendius wrote 4,321 Medicare prescriptions that cost $783K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 448 | 1,013 | 137 | $6,181 |
| Levetiracetam Generic | 268 | 604 | 63 | $12K |
| Gabapentin Generic | 237 | 427 | 72 | $4,967 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 176 | 380 | 44 | $6,181 |
| Ropinirole Hcl Generic | 147 | 334 | 35 | $4,970 |
| Meloxicam Generic | 129 | 169 | 28 | $325 |
| Lamotrigine Generic | 123 | 290 | 26 | $3,820 |
| Pregabalin Generic | 90 | 189 | 26 | $5,314 |
| Topiramate Generic | 88 | 192 | 22 | $943 |
| Sertraline Hcl Generic | 80 | 144 | 15 | $543 |
| Sumatriptan Succinate Generic | 76 | 93 | 17 | $704 |
| Tizanidine Hcl Generic | 75 | 124 | 24 | $659 |
| Trazodone Hcl Generic | 74 | 133 | 18 | $784 |
| Memantine Hcl Generic | 74 | 150 | 15 | $2,840 |
| Tramadol Hcl Generic | 72 | 72 | Under 11 | $350 |
Brand drugs: 299 claims; generic drugs: 4,005 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John R Mendius $15 ($15 in general payments such as food, travel and fees) from 1 company. The largest payer was UCB, Inc. with $15.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 1 | $15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.